Abstract
The role of surgery after 1rst-line alectinib for is largely unexplored. We aimed to describe the pathological features and surgical early-outcomes of patients undergoing salvage surgery in this framework
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have